Skip to main content
SpringerLink
Log in

Leber-Magen-Darm-Erkrankungen

  • Chapter
Arzneimitteltherapie für ältere Menschen

  • 49 Accesses

Zusammenfassung

Etwa 15% der deutschen Bevölkerung sind mehr als 60 Jahre alt. Die mittlere Lebenserwartung in Deutschland beträgt bei Frauen gegenwärtig 78,7 Jahre, bei Männern 72,2 Jahre. Der Anteil der über 60jährigen in der Bevölkerung hat seit 1910 um das Dreifache zugenommen. Demographischen Prognosen zufolge wird er im Jahre 2000 25% und 35% im Jahre 2030 betragen [2]. Die zunehmende Lebenserwartung und die sich ständig ausweitenden diagnostischen und therapeutischen Möglichkeiten stellen die Medizin vor spezielle Probleme beim älteren Patienten (s. a. Kapitel 1). Das trifft für die Gastroenterologie und Hepatologie in besonderem Maße zu. Aus physiologischer Sicht geht das Altern mit einer zunehmenden Einschränkung organspezifischer Reserveleistungen einher. Diese Einschränkung wird jedoch nur in außergewöhnlichen Belastungssituationen erkennbar, ist aber ansonsten symptom-und folgenlos. Aber sie kann beim alten Menschen dazu führen, daß Erkrankungen früher symptomatisch werden als bei Jüngeren. Bereits heute entfallen auf die knapp 20% der über 60jährigen etwa 50% aller rezeptpflichtigen Medikamentenverordnungen. Auch die Zahl der verordneten Medikamente nimmt zu. Ältere Patienten erhalten im Krankenhaus durchschnittlich 4,6 Medikamente täglich, ambulant behandelte 3,2 (s. a. Kapitel 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Holt PR (1995) Approach to gastrointestinal problems in the elderly. In: Yamada T(ed) Textbook of gastroentology, 2ne edn, vol. 2 Loppincott, Philadelphia. In: 968–988

    Google Scholar 

  2. Müller-Stein M, Lauter h (1988) Soziale Betreuung im höheren Lebensalter. In: Hippius H, Lauter H, Greil W (Hrsg) Psychiatrie für die Praxis, Bd 8: Psychische Störungen im höheren Lebensalter. MMV, München, S 68–74

    Google Scholar 

Literatur

  1. Adam R, Astarcioglu I, Azoulay D, Chiche L, Bao YM, Bastaing D, Bismuth H (1993) Liver transplantation from elderly donors. Transplant Proc 25: 1556–1557

    PubMed  CAS  Google Scholar 

  2. Aleyander JV, Vaughn WK, Cadrey MA (1991) The use of marginal donors for organ transplantation: The older and younger donors. Transplant Proc 23: 905–907

    Google Scholar 

  3. Birnbaum L, Baird M (1978) Induction of hepatic mixed function oxidases in senescent rodents. Exp Gerontol 4: 299–303

    Article  Google Scholar 

  4. Boyd WP (1989) Hepatobiliary disorders in geriatric gastroenterology. In: Sodeman WA, Saladin TA, Boyd WP (eds). Philadelphia, Saunders, p 193

    Google Scholar 

  5. Brouwer A, Barelds R, Knook DL (1985) Age-related changes in the capacity of rat liver Kupffer and endothelial cells. Hepatology 5: 362

    Article  PubMed  CAS  Google Scholar 

  6. Buckel E, Sanchez-Urdaspal L, Steers J, Sterioff S, Wiesner R, Krom RAF (1993) Impaired initial function in liver grafts from donors >50 years of age. Transplant Proc 25: 1558–1559

    PubMed  CAS  Google Scholar 

  7. Burns EA, Goodwin JS (1990) Immunology and infections. In: Cassel CK, Riesenberg DE, Sorensen LB, Walsh JR (eds) Geriatric Medicine, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 312–329

    Google Scholar 

  8. Castleden CM, George CF, Marcer D et al. (1977) Increased sensitivity to nitrazepam in old age. BMJ 1: 10

    Article  PubMed  CAS  Google Scholar 

  9. Crowley JJ, Cusack BJ, Jue SG et al. (1988) Aging and drug interactions. II. Effects of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men. J Pharmacol Exp Ther 245: 513–523

    PubMed  CAS  Google Scholar 

  10. Cusack BK, Nielson CP, Vestal RE (1996) Geriatric clinical pharmacology and therapeutics. In: Speight TM, Holford NHG (eds) Avery‘s drug treatment, 4th edn, pp 173–224

    Google Scholar 

  11. David H, Peinke P (1988) Liver morphology with aging. In: Bianchi L et al. (eds) Aging in liver and gastrointestinal tract. MTP, Lancester, pp 143–159

    Google Scholar 

  12. Davis GL (1998) Hepatitis C: Therapy. In: Hepatitis A to F: An update AASLD Postgraduate Course pp 246–256

    Google Scholar 

  13. Dimopoulou M, Fafoutis K, Basiliou K, Ketikoglou J, Karvountzins G (1993) Interferon alfa-2b for decompensated liver disease caused by either chronic hepatitis B or C: Preliminary results of a pilot study. Gut 34 [Suppl 2]: S104–105

    Article  PubMed  CAS  Google Scholar 

  14. Durnas C, Loi C-M, Cusack BJ (1990) Hepatic drug metabolism and aging. Clin Pharmacokinet 19: 349

    Article  Google Scholar 

  15. Emre S, Mor E, Schwartz ME, Katz E, Acarli K, Fukuzawa K, Miller CM (1993) Liver transplantation in patients beyond age 60. Transplant Proc 25: 1075–1076

    PubMed  CAS  Google Scholar 

  16. Epstein M (1979) Effect of aging on the kidney. Fed Proc 38: 168–172

    PubMed  CAS  Google Scholar 

  17. Falkson G, Cnaan A, Schutt AJ et al. (1988) Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 48: 7314

    PubMed  CAS  Google Scholar 

  18. Fisher CH, Sheff RN, Novak G et al. (1974) The effect of superior mesenteric artery vasopressin infusion on cardiac output and coronary blood flow in dogs. J Invest Radiol 9: 456

    Article  CAS  Google Scholar 

  19. Fitzgerald 0 (1972) Painless pancreatitis and other painless pancreatic disorders. Clin Gastroenterol 1: 195–218

    Google Scholar 

  20. Fujita S, Chiba M, Morimotoh-Satoh R, Kitani K, Suzuki T (1990) Possible mechanism for age-associated feminization of drug metabolizing ability of male rat liver. In: Kitani K (ed) Liver and aging. Elsevier, Amsterdam Oxford New York, pp 3–15

    Google Scholar 

  21. Ghadirian P, Simard A, Baillargeon J (1991) Tobacco, alcohol, and coffee and cancer of pancreas. Cancer 67: 2664–2670

    Article  PubMed  CAS  Google Scholar 

  22. Gibson PR, Dudley FJ (1984) Ischemic hepatitis: Clinical features, diagnosis and prognosis. Aust NZ J Med 14: 822

    Article  CAS  Google Scholar 

  23. Gullo L, Priori P, Daniele C, Ventrucci M, Gasbarrini G, Labo G (1983) Exocrine pancreatic function in the elderly. Gerontology 29: 407–411

    Article  PubMed  CAS  Google Scholar 

  24. Gullo L, Ventrucci M, Naldoni P, Pezzilli R (1986) Aging and exocrine pancreatic function in the elderly. J Am Geriatr Soc 34: 790–792

    PubMed  CAS  Google Scholar 

  25. Haddy TB, Castro OL, Rana SR (1988) Hereditary hemochromatosis in children, adolescent and young adults. Am J Pediatr Hematol Oncol 10: 23

    Article  PubMed  CAS  Google Scholar 

  26. Hale WE, Stewart RB, Marks RG (1983) Haematological and biochemical laboratory values in an ambulatory elderly population. An analysis of the effects of age, sex and drugs. Age Ageing 12: 275

    Article  PubMed  CAS  Google Scholar 

  27. Häussinger D, Maier KP (1996) Hepatische Enzephalopathie. Thieme, Stuttgart New York

    Google Scholar 

  28. Heinrich R, Schreckenberger A (1989) Normalbefunde am Gastrointestinaltrakt älterer Patienten. Z Geriatrie 2: 492–494

    Google Scholar 

  29. Hobson W, Jordon A (1959) A study of serum alkaline phosphatase levels in old people living at home. J Gerontol 14: 292

    PubMed  CAS  Google Scholar 

  30. Holt PR (1986) Gastrointestinal drugs in the elderly. Am J Gastroenterol 81: 403

    PubMed  CAS  Google Scholar 

  31. Imrie CW, Whyte AS (1975) A prospective study of acute pancreatitis. Br J Surg 62: 490–494

    Article  PubMed  CAS  Google Scholar 

  32. James OFW (1985) Drugs and the ageing liver. J Hepatol 1: 431

    Article  PubMed  CAS  Google Scholar 

  33. James OFW (1997) Parenchymal liver disease in the elderly. Gut 41: 430–432

    Article  PubMed  CAS  Google Scholar 

  34. Kampmann JP, Sinding J, Möller-Jorgensen I (1975) Effect of age on liver function. Geriatrics 30: 91

    PubMed  CAS  Google Scholar 

  35. Kew M, Bersohn I, Seftel H et al. (1970) Liver damage in heatstroke. Am J Med 4: 192

    Article  Google Scholar 

  36. Kitani K (1977) Aspects of the ageing liver. In: Platt D(ed). Liver and ageing, Schattauer Stuttgart New York 5.

    Google Scholar 

  37. Kuntz HD, Femfert B, May B (1986) Liver and ageing: Influence of age on liver function and drug metabolism. Dig Dis Sci 31: 195

    Google Scholar 

  38. Lai E (1992) Regulation of hepatic gene expression and development. Semin Liver Dis 12: 246–251

    Article  PubMed  CAS  Google Scholar 

  39. Lehman AB, Bassendine MF, James OFW (1985) Primary biliary cirrhosis: A different disease in the elderly? Gerontology 31: 2–14

    Article  Google Scholar 

  40. Lemon SM, Shapiro CN (1994) The value of immunization against hepatitis A. Infect Agents Dis 3: 38–49

    PubMed  CAS  Google Scholar 

  41. Meyers BR, Mendelsohn MH, Srulevitch-Chin E et al. (1987) Pharmacokinetic properties of mezlocillin in ambulatory elderly subjects. J Clin Pharmacol 27: 678–681

    PubMed  CAS  Google Scholar 

  42. Müllers-Stein M, Lauter H (1988) Soziale Betreuung im höheren Lebensalter. In: Hippius H, Lauter H, Greil W (Hrsg) Psychiatrie für die Praxis. Bd. 8: Psychische Störungen im höheren Lebensalter. MMV, München, S 68–74

    Google Scholar 

  43. Nebert DW, Gonzales FJ (1985) Cytochrome P-450 gene expression and regulations. TIPS 165: 160–164

    Google Scholar 

  44. Niederau C, Fischer R, Sonnenberg A et al. (1985) Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. Engl J Med 313: 1256

    Article  CAS  Google Scholar 

  45. Ochs HR, Verburg-Ochs B (1983) Einfluß von Alter, Gewicht, Geschlecht and Rauchgewohnheiten auf die Medikamentendosierung. Internist 24: 167

    PubMed  CAS  Google Scholar 

  46. Offerhaus GJA, Tersmette AC, Tersmette KWF et al. (1988) Gastric, pancreatic and colorectal carcinogenesis following remote peptic ulcer surgery. Mod Pathol 1: 352–356

    PubMed  CAS  Google Scholar 

  47. Park J, Fromkes J, Cooperman M (1986) Acute pancreatitis in elderly patients. Pathogenesis and outcome. Am J Surg 152: 638–642

    Article  PubMed  CAS  Google Scholar 

  48. Platt D (1995) Physiologische Alternsveränderungen and ihre Bedeutung für die Arzneimitteltherapie. Dtsch Ärztebl 34/35:C-1503–1506

    Google Scholar 

  49. Popper H (1985) Aging or withering of the liver? Hepatol Rapid Lit Rev 15: VII

    Google Scholar 

  50. Posner J, Danhof M, Teunissen MWE (1987) The disposition of antipyrine and its metabolites in young and elderly volunteers. Br J Clin Pharmacol 24: 51–55

    PubMed  CAS  Google Scholar 

  51. Reidenberg MM, Levy M, Warner H et al. (1978) The relationship between diazepam dose, plasma level age and central nervous system depression in adults. Clin Pharmacol Ther 23: 371

    PubMed  CAS  Google Scholar 

  52. Roll J, Boyer JL, Barry D et al. (1983) The prognostic importance of clinical and histological features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 308: 1

    Article  PubMed  CAS  Google Scholar 

  53. Schalm SW, Weiland O, Hansen BE et al. (1999) Interferon-Ribaverin for chronic hepatitis C with and without Cirrhosis: Analysis of individual patient data of six controlled trials. Gastroenterology 117: 408–413

    Article  PubMed  CAS  Google Scholar 

  54. Schulz HJ, Schreiber L, Birke S et al. (1980) Untersuchungen zur Morphologie and Funktion des exkretorischen Pankreas im Alter. Dtsch Gesundheitswesen 35: 533–538

    Google Scholar 

  55. Siegel JH, Kasmin FE (1997) Biliary tract diseases in the elderly: Management and outcomes. Gut 41: 433–435

    Article  PubMed  CAS  Google Scholar 

  56. Strohmeyer G, Rodilla-Sala E, Häussinger D (1995) Leber and Gastrointestinaltrakt im Alter. Der Internist 7: 639–647

    Google Scholar 

  57. Trautwein C, Manns MP (1995) Erkrankungen der Leber im Alter. Internist 7: 668–676

    Google Scholar 

  58. Trautwein C, Kiral G, Tillmann HL, Witteler H, Michel G, Manns MP (1995) Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union. J Med Virol 45: 429–434

    CAS  Google Scholar 

  59. Vestal RE, McGuire EA, Tobin JD et al. (1977) Aging and ethanol metabolism. Clin Pharmacol Ther 21: 343

    PubMed  CAS  Google Scholar 

  60. Vestal RE, Wood AJ, Shand DG (1989) Reduced beta-adrenoceptor sensitivity in the elderly. Clinical Pharmacol Ther 26: 181

    Google Scholar 

  61. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OFEW (1989) The effect of aging upon liver volume and apparent liver blood flow in healthy man. Hepatology 9: 297–301

    Article  PubMed  CAS  Google Scholar 

  62. Wynne HA, Cope LH, Herd B, Rawlins MD, James OFW, Woodhouse KW (1990) The association of age and frailty with paracetamol conjugation in man. Age Ageing 19: 419–424

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Bjarnason I, Zanelli G, Smith T et al (1987) Non-steriodal anti-inflammatory drug induced intestinal inflammation in man. Gastroenterology 93: 480–489

    PubMed  CAS  Google Scholar 

  2. Brynskov J, Freund L, Norby Rasmussen S, Lauritsen K, Schaffalitzky de Muckadell O, Williams CN, Macdonald AS, Tanton R, Molina F, Campanini MC, Bianchi P, Ranzi T, Quarto di Paulo F, Malcow-Moller A, Ostergaard Thomson O, Tage Jensen U, Binder V, Riffs P (1991) Final report of a placebo-controlled, double blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn’s disease. Scand J Gastroenterol 26: 689–695

    Article  PubMed  CAS  Google Scholar 

  3. Caesar J, Schölmerich J (1995) Entzündliche Darmerkrankungen. Neue therapeutische Perspektiven. Klinikarzt 24: 28–39

    Google Scholar 

  4. Caspary WF, Arnold R, Bayerdörffer E, Behrens R, Birkner B, Braden B, Domschke W, Labenz J, Koletzko S, Malfertheiner P, Menge H, Rösch W, Schepp W, Strauch M, Stolte M (1996) Diagnostik and Therapie der Helicobacter-pylori-Infektion. DGVS-Leitlinien I. Z Gastroenterol 34: 392–401

    PubMed  CAS  Google Scholar 

  5. Dajani AS, Bisno AL, Chung KJ, Durack DT, Freed M (1990) Prevention of bacterial endocarditis. Recommendations by the American Heart Assosiation. Clin Cardiol 12: 1919–1922

    Google Scholar 

  6. Daschner F (1998) Antibiotika am Krankenbett, 9. Aufl, Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  7. Ekström P, Carling S, Wetterhus P, Wingren PE, Anker-Hansen 0, Lundgardh G, Thorhallsson E, Unge P(1996) Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. Scand J Gastroenterol 31: 753–758

    Article  PubMed  Google Scholar 

  8. Ewe W, Weis HJ, Weihrauch TR (1992) Divertikulose, Divertikulitis. In: Wolff HP, Weihrauch TR (Hrsg) Internistische Therapie 1992/1993. Urban & Schwarzenberg, München Wien Baltimore, S 437–439

    Google Scholar 

  9. Feagan BG, Rocon J, Fedorak R, Irvine J, Wild G, Sutherland L, Steinhardt AH, Greenberg GR, Mc Donald J (1995) Methotrexate for the treatment of Crohn’s disease. N Engl J Med 332: 292–297

    Article  PubMed  CAS  Google Scholar 

  10. Gabriel SE, Jaakimainen L, Bombardier C (1991) Risk of serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med 115: 787–796

    PubMed  CAS  Google Scholar 

  11. Greenbloom SL, Steinhart AH, Greenberg GR (1995) Ciprofloxacin and metronidazole: Combination antibiotic therapy of ileocolonic Crohn’s disease. Gastroenterology 108: A827

    Article  Google Scholar 

  12. Greenwald DA, Brandt LJ (1998) Vascular abnormalities of the gastrointestinal tract. In: Feldman M, Scharschmidt BF, Sleisenger MH (eds), Sleisenger & Fordtran‘s Gastrointestinal and Liver Disease, vol 2, chap 119, 6. Saunders, Philadelphia London, edn. pp 2024–2034

    Google Scholar 

  13. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA (1991) Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114: 257–263

    PubMed  CAS  Google Scholar 

  14. Henry D, Lim LLY, Rodriguez LAG, Perez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312: 1563–1566

    Article  PubMed  CAS  Google Scholar 

  15. Hochain P, Berkelmans I, Czernichow P, Duhamel C, Tranvouez JL, Lerebours E, Colin R (1995) Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study. Eur J Gastroenterol Hepatol 7: 419–426

    PubMed  CAS  Google Scholar 

  16. Holt PR (1995) Approach to gastrointestinal problems in the elderly. In: Yamada T (ed) Textbook of gastroenterology, 2nd edn, vol 2. Lippincott, Philadelphia, pp 968–988

    Google Scholar 

  17. Koch M, Dezi A, Ferrario F, Capurso L (1996) Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Arch Intern Med 156: 2321–2321

    Article  PubMed  CAS  Google Scholar 

  18. Kohler B, Ginsbach C, Riemann JF (1989) Bacteriemia after laser therapy: In: Riemann JF, Ell C (Hrsg) Lasers in Gastroenterology. Thieme, Stuttgart New York, pp 147–150

    Google Scholar 

  19. Labenz J, Börsch, G (1996) Aktuelle Therapie der Helicobacter-pylori-Infektion. In: Malfertheiner P (eds.) Helicobacter pylori–Von der Grundlage zur Therapie, 2. Aufl. Thieme, Stuttgart, New York, S 149–163

    Google Scholar 

  20. Loeschke K, Ruckdeschel G (1992) Durchfälle unter Antibiotika. Diagnose and Therapie. Dtsch Ärztebl 89:B 221–224

    Google Scholar 

  21. Misiewicz G, Harris A (1995) Clinician‘s Manual on Helicobacter pylori. Science Press, London

    Google Scholar 

  22. Platt D (1995) Besonderheiten der Pharmakotherapie im Alter? Dtsch Ärztebl, 92: B1737–1741

    Google Scholar 

  23. Prantera C, Kohn A, Zannoni F, Spimpolo N, Bonfa M (1994) Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn‘s disease: results of an open study. J Clin Gastroenterol 19: 79–88

    Article  PubMed  CAS  Google Scholar 

  24. Sauter G, Ruckdeschel G, Sauerbruch T (1992) Antibiotische Prophylaxe and Therapie infektiöser Komplikationen. Z Gastroenterol 30: 705–709

    Google Scholar 

  25. Schölmerich J (1996) Therapie chronisch entzündlicher Darmerkrankungen. In: Klinik der Gegenwart, Bd 4, Kapitel 16. Urban & Schwarzenberg, München, S 1–44

    Google Scholar 

  26. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, Geis GS (1995) Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 123: 241–249

    PubMed  CAS  Google Scholar 

  27. Singleton JW, Hanauer S, Gitnick GL, Peppercorn MA, Robinson M, Wruble L, Krawitt E (1993) Pentasa Crohn‘s Disease Study Group: Mesalamine capsules for the treatment of active Crohn‘s disease: results of a 16-week trial. Gastroenterology 104: 1293–1301

    PubMed  CAS  Google Scholar 

  28. Taha AS, Hudson N, Hawkey CH, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI (1996) Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 334: 1435–1439

    Article  PubMed  CAS  Google Scholar 

  29. Weber JR, Ryan JC (1998) Effects on the gut of systemic disease and other extraintestinal conditions. In: Feldman M, Scharschmidt BF, Sleisenger MH (eds), Sleisenger & Fordtran‘s Gastrointestinal and Liver Disease, vol 1, chap 29, 6. edn. Saunders, Philadelphia London pp 429–438

    Google Scholar 

  30. Westergaard, H. (1998) Short Bowel Syndrome. In: Feldman M, Scharschmidt BF, Sleisenger MH (eds), Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, vol 2, chap 91, 6. edn. Saunders, Philadelphia London pp 1548–1556

    Google Scholar 

  31. Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR (1975) The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Investig 55: 347–359.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Strohmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Spamer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69-73, 14195, Berlin, Deutschland

    Franz von Bruchhausen

  2. Institut für Pharmakologie und Toxikologie, Universität Mannheim, Maybachstraße 14-16, 68169, Mannheim, Deutschland

    Björn Lemmer

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Strohmeyer, G., Spamer, C. (2000). Leber-Magen-Darm-Erkrankungen. In: von Bruchhausen, F., Lemmer, B. (eds) Arzneimitteltherapie für ältere Menschen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59590-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59590-5_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-64851-2

  • Online ISBN: 978-3-642-59590-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation